000			01545 a2200433 4500
005			20250515012456.0
264		0	_c20060511
008			200605s 0 0 por d
022			_a0066-782X
024	7		_a/S0066-782X2005002400002 _2doi
040			_aNLM _beng _cNLM
100	1		_aMartinez, Tania Leme da Rocha
245	0	0	_a[Special recommendations for lipid-lowering treatment: efficacy and safety]. _h[electronic resource]
260			_bArquivos brasileiros de cardiologia _cOct 2005
300			_a6-8 p. _bdigital
500			_aPublication Type: English Abstract; Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAlanine Transaminase _xblood
650	0	4	_aAspartate Aminotransferases _xblood
650	0	4	_aBiomarkers _xblood
650	0	4	_aCoronary Artery Disease _xprevention & control
650	0	4	_aCreatine Kinase _xblood
650	0	4	_aDrug Monitoring _xmethods
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadverse effects
650	0	4	_aHyperlipidemias _xdrug therapy
650	0	4	_aLiver _xdrug effects
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPractice Guidelines as Topic
650	0	4	_aPractice Patterns, Physicians' _xstandards
650	0	4	_aTime Factors
700	1		_aNascimento, Helena Maria do
773	0		_tArquivos brasileiros de cardiologia _gvol. 85 Suppl 5 _gp. 6-8
856	4	0	_uhttps://doi.org//S0066-782X2005002400002 _zAvailable from publisher's website
999			_c16017665 _d16017665